Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KBL697 in moderate plaque psoriasis
NCT04911751Phase 2Completed
- Sponsor
- KoBioLabs
- Start
- Nov 2021
- Primary completion
- Nov 2023
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 2
01
Overview
A Phase 2 trial of Lactobacillus gasseri KBL697 in plaque psoriasis, sponsored by KoBioLabs. Started Nov 2021; status: completed.
02
Drugs
Lactobacillus gasseri KBL697
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT04911751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04911751.